Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turki Alfayea

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2020
Immunotherapy and Coronavirus Disease 2019: Challenges and PossibilitiesHatoon Bakhribah, Turki Alfayea
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Case Series: EGFR and ROS-1 Co-Occurrence in Advanced Non-Small Cell Lung CancerTurki Alfayea, Alaa A Salim, Mohammad Alkaiyat, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 26, 2021
Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysisAlaa Shahbar, Majed Alshamrani, Mohammed Aseeri, et al.
Cancer Treatment and Research Communications|September 11, 2022
Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysisMajed Ramadan, Turki Alfayea, Abeer Alsofyani, et al.
BMC Nursing|October 27, 2022
Prevalence and factors associated with burnout among nurses in Jeddah: a single-institution cross-sectional studyJumanah T Qedair, Renad Balubaid, Raghad Almadani, et al.
Women'S Health (London, England)|October 31, 2022
Level and predictors of breast cancer awareness among Saudi women: A nationwide studyJumanah T Qedair, Abdullah A Al Qurashi, Turki Alfayea, et al.
JCO Global Oncology|August 5, 2020
Expression of Immune Response Markers in Arab Patients With Lung CancerAbdul Rahman Jazieh, Adda Bounedjar, Hanaa Bamefleh, et al.
Expert Review of Clinical Pharmacology|April 30, 2025
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare systemMansoor A Khan, Laila Carolina Abu Esba, Consuela Cheriece Yousef, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2020
Immunotherapy and Coronavirus Disease 2019: Challenges and PossibilitiesHatoon Bakhribah, Turki Alfayea
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Case Series: EGFR and ROS-1 Co-Occurrence in Advanced Non-Small Cell Lung CancerTurki Alfayea, Alaa A Salim, Mohammad Alkaiyat, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 26, 2021
Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysisAlaa Shahbar, Majed Alshamrani, Mohammed Aseeri, et al.
Cancer Treatment and Research Communications|September 11, 2022
Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysisMajed Ramadan, Turki Alfayea, Abeer Alsofyani, et al.
BMC Nursing|October 27, 2022
Prevalence and factors associated with burnout among nurses in Jeddah: a single-institution cross-sectional studyJumanah T Qedair, Renad Balubaid, Raghad Almadani, et al.
Women'S Health (London, England)|October 31, 2022
Level and predictors of breast cancer awareness among Saudi women: A nationwide studyJumanah T Qedair, Abdullah A Al Qurashi, Turki Alfayea, et al.
JCO Global Oncology|August 5, 2020
Expression of Immune Response Markers in Arab Patients With Lung CancerAbdul Rahman Jazieh, Adda Bounedjar, Hanaa Bamefleh, et al.
Expert Review of Clinical Pharmacology|April 30, 2025
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare systemMansoor A Khan, Laila Carolina Abu Esba, Consuela Cheriece Yousef, et al.
Pageof 1